
Can-Fite BioPharma Ltd. CANF
€ 0.25
-0.31%
Geschäftsbericht 2024
hinzugefügt 29.11.2025
Can-Fite BioPharma Ltd. ROCE 2011-2025 | CANF
ROCE Jährlich Can-Fite BioPharma Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -115.03 | -102.84 | -148.89 | -73.29 | -171.3 | -244.89 | -112.02 | 82.74 | 91.65 | 32.02 | 281.75 | -200.03 | 870.47 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 870.47 | -244.89 | 14.64 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
ARCA biopharma
ABIO
|
-23.06 | - | 1052.0 % | $ 415 M | ||
|
AbbVie
ABBV
|
274.8 | $ 223.98 | -0.53 % | $ 396 B | ||
|
Alpine Immune Sciences
ALPN
|
-32.41 | - | - | $ 2.17 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
-73.67 | $ 4.67 | 1.74 % | $ 775 M | ||
|
Aclaris Therapeutics
ACRS
|
-91.24 | $ 3.36 | 2.75 % | $ 260 M | ||
|
AlloVir
ALVR
|
-57.76 | - | 4.14 % | $ 49.1 M | ||
|
Acasti Pharma
ACST
|
-25.04 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-353.66 | - | -15.15 % | $ 60.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-75.24 | - | -11.43 % | $ 502 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-40.28 | - | - | $ 1.01 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
17.36 | - | - | $ 40.3 B | ||
|
Albireo Pharma
ALBO
|
-70.32 | - | -0.23 % | $ 916 M | ||
|
Ascendis Pharma A/S
ASND
|
-45.89 | $ 210.16 | 4.43 % | $ 5 B | ||
|
Ayala Pharmaceuticals
AYLA
|
3412.47 | - | - | $ 7.46 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-104.38 | $ 3.42 | 2.09 % | $ 8.23 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-61.36 | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.05 | $ 25.9 | 0.74 % | $ 1.25 B | ||
|
AstraZeneca PLC
AZN
|
11.12 | $ 90.29 | - | $ 96.9 B | ||
|
Anika Therapeutics
ANIK
|
-41.29 | $ 9.49 | - | $ 139 M | ||
|
Brickell Biotech
BBI
|
-64.05 | - | -5.38 % | $ 6.06 M | ||
|
BeiGene, Ltd.
BGNE
|
-15.33 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
-1339.01 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
-69.03 | - | -7.31 % | $ 87 M | ||
|
Aytu BioScience
AYTU
|
-12.81 | $ 2.28 | - | $ 14.3 M | ||
|
Arena Pharmaceuticals
ARNA
|
-92.73 | - | -6.81 % | $ 3.04 B | ||
|
Biogen
BIIB
|
31.45 | $ 172.5 | - | $ 25.1 B | ||
|
Baudax Bio
BXRX
|
234.36 | - | 0.59 % | $ 63 K | ||
|
Avenue Therapeutics
ATXI
|
-403.4 | - | -52.27 % | $ 4.45 M | ||
|
Benitec Biopharma
BNTC
|
-10.11 | $ 12.96 | 1.17 % | $ 533 M | ||
|
Институт стволовых клеток человека
ISKJ
|
15.18 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
16.76 | - | -0.88 % | $ 598 M | ||
|
Axon Enterprise
AXON
|
2.51 | $ 581.03 | 2.22 % | $ 44 B | ||
|
Checkpoint Therapeutics
CKPT
|
444.94 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-75.78 | - | -16.75 % | $ 25.8 M | ||
|
Catalyst Biosciences
CBIO
|
424.75 | $ 15.31 | - | $ 1.01 B | ||
|
Clovis Oncology
CLVS
|
80.97 | - | -7.23 % | $ 13 M | ||
|
Cerus Corporation
CERS
|
-25.34 | $ 2.15 | 13.76 % | $ 397 M | ||
|
BioVie
BIVI
|
-95.03 | $ 1.51 | -4.43 % | $ 2.23 M | ||
|
Cortexyme
CRTX
|
-40.69 | - | -1.05 % | $ 67.1 M | ||
|
Celldex Therapeutics
CLDX
|
-26.11 | $ 27.94 | - | $ 1.8 M | ||
|
Cellectar Biosciences
CLRB
|
257.01 | $ 3.78 | -5.97 % | $ 46.2 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-60.12 | - | - | $ 2.18 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
95.22 | $ 11.44 | 7.92 % | $ 740 M | ||
|
BioNTech SE
BNTX
|
-4.81 | $ 96.0 | - | $ 27.2 B | ||
|
Eloxx Pharmaceuticals
ELOX
|
322.88 | - | -5.68 % | $ 8.28 M | ||
|
Acer Therapeutics
ACER
|
146.85 | - | 2.71 % | $ 14 M | ||
|
Enochian Biosciences
ENOB
|
903.05 | - | - | $ 40.5 M | ||
|
Epizyme
EPZM
|
1150.39 | - | - | $ 249 M |